Skip to main content

Nektar Therapeutics

NKTR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000906709

In the last 90 days, Nektar Therapeutics insiders filed 0 open-market purchases and 2 sales; 239 institutions reported holding it in 13F filings for Q2 2026, worth $2.50B in total; no superinvestor holds it.

13F holders, Q3 2024

Institutional positions in Nektar Therapeutics as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
140
+6 vs. Q2 2024
Shares held
140.8M
+20.5M (+17.0%) vs. Q2 2024
Total value
$182.9M
+$33.8M (+22.6%) vs. Q2 2024
New holders
23
37 more added
Sold out
17
34 more reduced

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting NKTR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2024: 140 institutions
Q1 2021: 239 institutionsQ2 2021: 243 institutionsQ3 2021: 243 institutionsQ4 2021: 242 institutionsQ1 2022: 243 institutionsQ2 2022: 230 institutionsQ3 2022: 232 institutionsQ4 2022: 217 institutionsQ1 2023: 197 institutionsQ2 2023: 148 institutionsQ3 2023: 139 institutionsQ4 2023: 127 institutionsQ1 2024: 123 institutionsQ2 2024: 135 institutionsQ3 2024: 140 institutionsQ4 2024: 146 institutionsQ1 2025: 157 institutionsQ2 2025: 109 institutionsQ3 2025: 153 institutionsQ4 2025: 180 institutionsQ1 2026: 216 institutionsQ2 2026: 239 institutions
Value heldQ3 2024: $182.9M
Q1 2021: $3.40BQ2 2021: $2.89BQ3 2021: $3.01BQ4 2021: $2.35BQ1 2022: $947.6MQ2 2022: $693.8MQ3 2022: $561.4MQ4 2022: $381.7MQ1 2023: $121.2MQ2 2023: $79.3MQ3 2023: $85.3MQ4 2023: $67.3MQ1 2024: $105.5MQ2 2024: $168.0MQ3 2024: $182.9MQ4 2024: $123.6MQ1 2025: $84.2MQ2 2025: $197.7MQ3 2025: $820.2MQ4 2025: $732.2MQ1 2026: $1.94BQ2 2026: $2.50B
Institutions holding NKTR and their total value by quarter
QuarterHoldersValue
Q2 2026239$2.50B
Q1 2026216$1.94B
Q4 2025180$732.2M
Q3 2025153$820.2M
Q2 2025109$197.7M
Q1 2025157$84.2M
Q4 2024146$123.6M
Q3 2024140$182.9M
Q2 2024135$168.0M
Q1 2024123$105.5M
Q4 2023127$67.3M
Q3 2023139$85.3M
Q2 2023148$79.3M
Q1 2023197$121.2M
Q4 2022217$381.7M
Q3 2022232$561.4M
Q2 2022230$693.8M
Q1 2022243$947.6M
Q4 2021242$2.35B
Q3 2021243$3.01B
Q2 2021243$2.89B
Q1 2021239$3.40B

Institutions, Q3 2024

Shares, value and share of portfolio for each institution holding Nektar Therapeutics; share changes are against Q2 2024.

Institutions holding NKTR in Q3 2024
InstitutionSharesValue% of portfolioChange in sharesAction
US Bancorp17,000$22.1K0.00%00.0%Unchanged
Neuberger Berman Group LLC16,293$21.2K0.00%+16,293New
Parallel Advisors, LLC15,820$20.6K0.00%00.0%Unchanged
Legal & General Group Plc15,399$20.0K0.00%00.0%Unchanged
Engineers Gate Manager LP13,398$17.4K0.00%+13,398New
Maltin Wealth Management, Inc.13,000$16.9K0.01%00.0%Unchanged
Blair William & Co12,944$16.8K0.00%00.0%Unchanged
California State Teachers Retirement System12,936$16.8K0.00%00.0%Unchanged
JustInvest LLC12,932$16.8K0.00%+94+0.7%Added
Captrust Financial Advisors12,748$16.6K0.00%+748+6.2%Added
Cetera Investment Advisers12,638$16.4K0.00%−1,550−10.9%Reduced
Principal Financial Group Inc12,455$16.2K0.00%−5,050−28.8%Reduced
LGT Group Foundation11,246$15.0K0.00%00.0%Unchanged
Altium Capital Management LP11,419$14.8K0.00%+11,419New
Xponance, Inc.10,798$14.0K0.00%−656−5.7%Reduced
Allworth Financial LP10,140$13.2K0.00%00.0%Unchanged
Intellectus Partners, LLC10,000$13.0K0.00%00.0%Unchanged
Simplex Trading, LLC6,988$9.00K0.00%+4,737+210.4%Added
Amalgamated Bank6,177$8.00K0.00%00.0%Unchanged
CWM, LLC3,355$4.00K0.00%+3,355New
Activest Wealth Management3,000$3.90K0.00%00.0%Unchanged
Compass Wealth Management LLC2,000$2.60K0.00%00.0%Unchanged
GWM Advisors LLC1,500$1.95K0.00%00.0%Unchanged
Federated Hermes, Inc.1,256$1.63K0.00%00.0%Unchanged
Brown Brothers Harriman & Co1,000$1.30K0.00%−300−23.1%Reduced
Founders Capital Management700$9100.00%00.0%Unchanged
Sterling Capital Management LLC567$7370.00%+567New
Nisa Investment Advisors, LLC317$4120.00%+317New
AllSquare Wealth Management LLC277$3600.00%00.0%Unchanged
Smartleaf Asset Management LLC282$3290.00%+282New
Kimelman & Baird, LLC200$2600.00%00.0%Unchanged
Signaturefd, LLC200$2600.00%00.0%Unchanged
Versant Capital Management, Inc169$2200.00%00.0%Unchanged
Harbour Investments, Inc.155$2020.00%00.0%Unchanged
Capital Performance Advisors LLP66$860.00%+66New
Salomon & Ludwin, LLC46$600.00%00.0%Unchanged
Steward Partners Investment Advisory, LLC40$520.00%00.0%Unchanged
Global Retirement Partners, LLC16$210.00%00.0%Unchanged
Huntington National Bank1$10.00%00.0%Unchanged
Covestor Ltd5$00.00%00.0%Unchanged
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main0$00.00%−187,385−100.0%Sold out
Alpine Global Management, LLC0$00.00%−175,168−100.0%Sold out
Virtu Financial LLC0$00.00%−75,063−100.0%Sold out
Susquehanna International Group, LLP0$00.00%−64,928−100.0%Sold out
Paloma Partners Management Co0$00.00%−55,229−100.0%Sold out
Toroso Investments, LLC0$00.00%−42,500−100.0%Sold out
US Asset Management LLC0$00.00%−37,861−100.0%Sold out
Prospera Financial Services Inc0$00.00%−29,244−100.0%Sold out
First Trust Investment Solutions L.P.0$00.00%−20,000−100.0%Sold out
HighTower Advisors, LLC0$00.00%−18,608−100.0%Sold out
Marathon Trading Investment Management LLC0$00.00%−16,877−100.0%Sold out
Qube Research & Technologies Ltd0$00.00%−16,304−100.0%Sold out
Franklin Street Advisors Inc0$00.00%−15,500−100.0%Sold out
Picton Mahoney Asset Management0$00.00%−2,747−100.0%Sold out
Atlas Capital Advisors LLC0$00.00%−600−100.0%Sold out
WealthCollab, LLC0$00.00%−300−100.0%Sold out
Princeton Global Asset Management LLC0$00.00%−100−100.0%Sold out
BlackRock Inc.––––Not filed